Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA Approves Johnson and Johnson Blood Cancer Drug Tecvayli-Darzalex Combo

Johnson & Johnson MedTech completes first cases with OTTAVA Robotic Surgical System

Written By Ruchika Sharma15 April 2025 11:45 AM IST

Upon completion of the study, the company plans to submit the OTTAVA system for De Novo authorization in the United States.

Pfizer discontinues development of danuglipron for chronic weight management

Written By Ruchika Sharma14 April 2025 5:41 PM IST

New York: Pfizer Inc. has announced the company has discontinued the development of danuglipron (PF-06882961), an oral glucagon-like...

Multi-drug resistant infections medicine 'Zaynich' to get USFDA approval next year: Wockhardt Chairman

Written By Ruchika Sharma14 April 2025 3:49 PM IST

Dubai: Zaynich, a multi-drug resistant infections medicine, is set to receive the US Food and Drug Administration (USFDA) approval in 2026,...

Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France for USD 300 million

Arthritis drug: Sandoz files US antitrust litigation against Amgen

Written By Ruchika Sharma14 April 2025 2:30 PM IST

Sandoz is seeking an injunction to prevent Amgen from using certain patent rights to block biosimilar competition and allow Sandoz to launch Erelzi.

Dr Reddys, Zydus recall products in US over manufacturing issues

Sun Pharma, Zydus and Glenmark recall various products in US over manufacturing issues

Written By Ruchika Sharma14 April 2025 1:30 PM IST

Sun Pharma, Zydus, and Glenmark are recalling various products in the US market due to manufacturing-related concerns, the US health regulator...

Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry

Roche Columvi gets European Commission nod as bispecific antibody for diffuse large B-cell lymphoma after initial therapy

Written By Ruchika Sharma14 April 2025 12:30 PM IST

Basel: Roche has announced that the company has received approval from the European Commission for Columvi (glofitamab) in...

After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug Nereus

Aurobindo Pharma gets USFDA final, tentative nod for different strengths of deep vein thrombosis drug Rivaroxaban

Written By Ruchika Sharma14 April 2025 11:30 AM IST

Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and...

CDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibbs Mavacamten Study

Pomalyst monopoly case: Bristol Myers wins dismissal of lawsuit

Written By Ruchika Sharma13 April 2025 11:00 AM IST

A federal judge in New York has dismissed a proposed class action against pharmaceutical giant Bristol Myers Squibb, which accused the company of...

Zydus Lifesciences bags USFDA nod for Duchenne muscular dystrophy drug Jaythari

Written By Ruchika Sharma12 April 2025 11:30 AM IST

Ahmedabad: Pharma major, Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA)...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

Aurobindo Pharma arm gets 11 USFDA observations for Raleigh Plant

Written By Ruchika Sharma11 April 2025 5:46 PM IST

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) has issued 11 observations after an...

From Teriparatide to Pembrolizumab: CDSCO Clears Import of r-DNA Drugs via CT-18 Route

USFDA plans to phase out animal testing requirement for monoclonal antibodies, other drugs

Written By Ruchika Sharma11 April 2025 4:08 PM IST

In a significant move toward modernizing drug development, the U.S. Food and Drug Administration (USFDA) has announced plans to phase out its...

USFDA Approves Corcept Therapeutics Ovarian Cancer Drug Lifyorli

Biocon arm secures USFDA approval for Everolimus Tablets for prophylaxis of organ rejection in adult patients

Written By Ruchika Sharma11 April 2025 12:30 PM IST

Bangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok